Mirum Pharmaceuticals, Inc.
VISTAS
Fragile X syndrome
Resolved
7days ago
Phase 2 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 2 trial results for VISTAS in Fragile X syndrome are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“VISTAS Phase 2b positive interim analysis, confirmatory topline data expected Q2 2026”